Cell-Based Therapy for Myocardial Dysfunction After Fontan Operation in Hypoplastic Left Heart Syndrome

Myocardial dysfunction after Fontan palliation for univentricular congenital heart disease is a challenging clinical problem. The medical treatment has a limited impact, with cardiac transplant being the ultimate management step. Cell-based therapies are evolving as a new treatment for heart failure...

Descripción completa

Detalles Bibliográficos
Autores principales: Qureshi, Muhammad Y., Cabalka, Allison K., Khan, Shakila P., Hagler, Donald J., Haile, Dawit T., Cannon, Bryan C., Olson, Timothy M., Cantero-Peral, Susana, Dietz, Allan B., Radel, Darcie J., Taggart, Nathan W., Kelle, Angela M., Rodriguez, Vilmarie, Dearani, Joseph A., O’Leary, Patrick W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134900/
https://www.ncbi.nlm.nih.gov/pubmed/30225415
http://dx.doi.org/10.1016/j.mayocpiqo.2017.07.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134900/
https://www.ncbi.nlm.nih.gov/pubmed/30225415
http://dx.doi.org/10.1016/j.mayocpiqo.2017.07.002

Ejemplares similares